HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral intake and serum levels of ascorbic acid in continuous ambulatory peritoneal dialysis patients.

Abstract
Oral intake of ascorbic acid is essential for optimum health in human beings. Continuous ambulatory peritoneal dialysis (CAPD) patients have an increased need for ascorbic acid, because of increased loss through dialysate, reduced intake owing to nausea and loss of appetite, and increased oxidative stress. However, optimum intake is still controversial. We studied 50 clinically stable patients to determine the relationship between oral ascorbic acid intake and serum ascorbic acid (SAA) level. Total oral intake ranged from 28 mg daily to 412 mg daily. Only one patient had an oral intake of ascorbic acid below 60 mg per day. The SAA levels ranged from 1 mg/L to 36.17 mg/L. Although a strong correlation existed between intake and SAA (p < 0.001, R2 = 0.47), the variation in SAA at any given intake level was wide. Of the studied patients, 62% had an SAA < 8.7 mg/L, 40% had an SAA < 5.1 mg/L (below the level in a healthy population), and 12% had a level below 2 mg/L (scorbutic). None of the patients demonstrated clinical manifestations of scurvy. Our results show that, in CAPD patients, ascorbic acid deficiency can be reliably detected only with SAA measurements, and oral intake may influence SAA level. To maintain ascorbic acid in the normal range for healthy adults, daily oral intake needs to be increased above the U.S. recommended dietary allowance to 80-140 mg.
AuthorsS L Lim, E J Lee, C C Myint, K T Ong, M E Tay, N Yusuf, C N Ong
JournalAdvances in peritoneal dialysis. Conference on Peritoneal Dialysis (Adv Perit Dial) Vol. 17 Pg. 215-8 ( 2001) ISSN: 1197-8554 [Print] Canada
PMID11510279 (Publication Type: Journal Article)
Chemical References
  • Ascorbic Acid
Topics
  • Aged
  • Aged, 80 and over
  • Ascorbic Acid (administration & dosage, blood)
  • Ascorbic Acid Deficiency (diagnosis)
  • Diet
  • Dietary Supplements
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peritoneal Dialysis, Continuous Ambulatory

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: